Navigation Links
Niche Pharmaceuticals, Inc. Asks "Are You Ready to Get Your Life Back from Chronic Migraines?"
Date:12/9/2015

SOUTHLAKE, Texas, Dec. 9, 2015 /PRNewswire/ -- Niche Pharmaceuticals, Inc. has launched a microsite (www.MagnesiumRoadtoMigrainePrevention.com) which features an overview of the research done on the link between magnesium deficiency and chronic migraine headaches. Niche Pharmaceuticals invites people with chronic migraine headaches to explore the site to better understand findings on the connection between low magnesium and migraine headaches.

Published clinical trials (1) have shown that daily magnesium supplementation taken for a minimum of two to three months can reduce the occurrence of migraine days by at least fifty percent. Results will vary per individual. In fact, the American Headache Society and the American Academy of Neurology now include oral magnesium in their preventive treatment guidelines for migraines (2). There is strong evidence that magnesium deficiency is much more prevalent in those with chronic migraine headaches than in healthy controls. 

Mag-Tab®SR is Niche's magnesium product that has a unique formulation that delivers magnesium L-lactate dihydrate into the body slowly for maximum absorption. Taken daily, Mag-Tab®SR provides twenty-four hours of continuous magnesium supplementation. The slow release component leads to better uptake in the body's cells and relief of many symptoms associated with magnesium deficiency. 

According to the company's founder and CEO, Steve F. Brandon, studies show(3) approximately four out of five people in the United States do not get enough magnesium in their diet and may be magnesium deficient. Up to fifty percent of the thirty-six million American migraine sufferers have low magnesium levels associated with their chronic migraines (4). This is especially true for women (5). Doctors recommend non-prescription Mag-Tab®SR because it is a sustained release magnesium supplement that is highly absorbed and well-tolerated by the gastrointestinal tract(6).

A "Migraine Prevention" pack with two bottles of one hundred caplets and a free sixty count bottle are available as part of the campaign and can be purchased at http://www.magnesiumroadtomigraineprevention.com. The pack contains two months' worth of daily magnesium intake and participants will receive a discount code for their next purchase at magtabsr.com, the company's website. Migraineurs are invited to share their progress and results on Mag-Tab® SR's Facebook page (www.facebook.com/magtabsr), tweet to @magtabsr, and use the mobile migraine tracking app Migraine Buddy where a Mag-Tab®SR group has been created.

About Niche Pharmaceuticals, Inc.
Niche Pharmaceuticals, Inc. was founded in 1991 to develop and market ethical pharmaceutical grade nutraceutical products that fulfill unmet medical needs. Over the years, Niche has a developed a reputable base of U.S. and International doctors who recommend Mag-Tab®SR, a non-prescription magnesium supplement. Niche has also dedicated considerable financial resources towards developing the first Rx oral magnesium product for the prevention of migraine headaches with major clinical trials now underway across the US.

Media Contact:
Steve Brandon 
Niche Pharmaceuticals, Inc. 
580 Commerce St, Ste. 100 
Southlake, Texas 76092 
800-677-0355
817-421-2777
www.magnesiumroadtomigraineprevention.com
www.magtabsr.com 
info@magtabsr.com

Citations

(1) http://www.ncbi.nlm.nih.gov/pubmed/18705538

(2) http://tools.aan.com/professionals/practice/pdfs/gl0090.pdf

(3) http://www.foxnews.com/health/2013/11/23/7-nutrients-lacking-in-your-diet.html

(4) https://migraine.com/pro/migraine-prevalence-and-incidence/

(5) https://migraine.com/pro/migraine-prevalence-and-incidence/

(6) http://www.magtabsr.com/template/pdf/Bioavailability-and-Pharmacokinetics-of-Mg-After-Admin-of-Mg-Salts-in-Humans.pdf

 

Photo - http://photos.prnewswire.com/prnh/20151207/293835
Photo - http://photos.prnewswire.com/prnh/20151207/293836

 


'/>"/>
SOURCE Niche Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets
2. Percutaneous Coronary Intervention Devices: Niche Opportunities Emerge in Western Europe
3. Global Gelatin and Gelatin Derivatives Isinglass and Bone Glues Market in Europe 2014-2018: Key Vendors are AB Vickers, Corngroup, Fritz Hacker GmbH & Co, Gelita, Kerry Ingredients and Flavours and Menichetti
4. Laboratory Glassware And Plasticware - 2012 Global Strategic Business Report Profiles 91 Companies Including Many Key and Niche Players
5. KaloBios Pharmaceuticals, Inc. Raises $8.2 Million in Private Placement
6. KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New Financing
7. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2015
8. Ground Zero Pharmaceuticals, Inc. (GZP) Announces New Additions, Services for its Global Clients
9. Global Hyperphosphatemia Drugs Market 2015-2019 with Fresenius Medical Care, Keryx Biopharmaceuticals, Sanofi, Shire & Vifor Pharma Dominating
10. ContraVir Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock And Warrants
11. Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):